← 產業報告目錄
Cancer-focused Genetic Testing Service Market Size, Share & Trends Analysis Report By Test Type (Chromosome Testing, DNA Testing, Direct DNA Testing, Indirect DNA Testing, Biochemical Genetic Testing), By Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer, Bladder Cancer, Kidney Cancer, Other), By Service Provider, By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-10頁數 175報告編號 INSIGHTACE-673067323b
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Valued at USD 7.82 billion as of 2023, the global Cancer-focused Genetic Testing Service Market is poised to climb to USD 14.41 billion by 2031, reflecting a compound annual growth rate of 8.2% over the 2024–2031 period.
At its core, Cancer-focused Genetic Testing Service pertains to an essential part of contemporary oncology, providing substantial advantages in evaluating risk, preventing the disease, and tailoring trea. Stakeholders across the healthcare landscape are surgingly turning to these solutions to meet contemporary demands.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the surging emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and surging investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cancer-Focused Genetic Testing Service Market Snapshot
Chapter 4. Global Cancer-Focused Genetic Testing Service Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Test Type Estimates & Trend Analysis
5.1. By Test Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Test Type:
5.2.1. Chromosome
5.2.2. DNA
5.2.3. Direct DNA Testing
5.2.4. Indirect DNA Testing
5.2.5. Biochemical
Chapter 6. Market Segmentation 2: By Cancer Type Estimates & Trend Analysis
6.1. By Cancer Type & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Cancer Type:
6.2.1. Breast Cancer
6.2.2. Colorectal Cancer
6.2.3. Lung Cancer
6.2.4. Bladder Cancer
6.2.5. Kidney Cancer
6.2.6. Other Cancer Types
Chapter 7. Market Segmentation 3: By Service Provider Estimates & Trend Analysis
7.1. By Service Provider & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Service Provider:
7.2.1. Hospitals
7.2.2. Specialty Clinics
7.2.3. Diagnostic Laboratories
7.2.4. Specialized Cancer Institutes
Chapter 8. Cancer-Focused Genetic Testing Service Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
8.1.2. North America Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Cancer Type, 2024-2031
8.1.3. North America Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Service Provider, 2024-2031
8.1.4. North America Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
8.2.2. Europe Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Cancer Type, 2024-2031
8.2.3. Europe Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Service Provider, 2024-2031
8.2.4. Europe Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
8.3.2. Asia Pacific Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Cancer Type, 2024-2031
8.3.3. Asia Pacific Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Service Provider, 2024-2031
8.3.4. Asia Pacific Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Asia Pacific Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
8.4.2. Latin America Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Cancer Type, 2024-2031
8.4.3. Latin America Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Service Provider, 2024-2031
8.4.4. Latin America Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
8.5.2. Middle East & Africa Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Cancer Type, 2024-2031
8.5.3. Middle East & Africa Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by Service Provider, 2024-2031
8.5.4. Middle East & Africa Cancer-Focused Genetic Testing Service Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Cleveland Clinic
9.2.2. Fortis Healthcare
9.2.3. KIMS Hospitals
9.2.4. Rush University Medical Center
9.2.5. The Johns Hopkins Hospital
9.2.6. Bridgeport Hospital
9.2.7. Greenwich Hospital
9.2.8. Lawrence Memorial Hospital
9.2.9. Westerly Hospital
9.2.10. Yale New Haven Hospital
9.2.11. Northeast Medical Group
9.2.12. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們